Pharmaxis to Be Renamed Syntara and Will Primarily Focus on Clinical Development
Pharmaxis to Be Renamed Syntara and Will Primarily Focus on Clinical Development
Pharmaxis 將更名爲 Syntara，將主要專注於臨床開發
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間